JP2008537958A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008537958A5 JP2008537958A5 JP2008506722A JP2008506722A JP2008537958A5 JP 2008537958 A5 JP2008537958 A5 JP 2008537958A5 JP 2008506722 A JP2008506722 A JP 2008506722A JP 2008506722 A JP2008506722 A JP 2008506722A JP 2008537958 A5 JP2008537958 A5 JP 2008537958A5
- Authority
- JP
- Japan
- Prior art keywords
- polypeptide
- wisp
- domain
- cancer cells
- cancer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11/105,876 US7455834B2 (en) | 2002-06-29 | 2005-04-14 | Methods and compositions for modulating and detecting WISP activity |
| US11/105,876 | 2005-04-14 | ||
| PCT/US2006/014008 WO2006113402A1 (en) | 2005-04-14 | 2006-04-13 | Methods and compositions for modulating and detecting wisp activity |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2008537958A JP2008537958A (ja) | 2008-10-02 |
| JP2008537958A5 true JP2008537958A5 (cg-RX-API-DMAC7.html) | 2009-05-28 |
| JP4979684B2 JP4979684B2 (ja) | 2012-07-18 |
Family
ID=36809580
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008506722A Expired - Lifetime JP4979684B2 (ja) | 2005-04-14 | 2006-04-13 | Wisp活性を調節し検出するための方法及び組成物 |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US7455834B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1869086B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP4979684B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR101320261B1 (cg-RX-API-DMAC7.html) |
| CN (1) | CN101198623B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2006236649B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BRPI0612184A8 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2604933C (cg-RX-API-DMAC7.html) |
| ES (1) | ES2388993T3 (cg-RX-API-DMAC7.html) |
| IL (1) | IL186095A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2007012798A (cg-RX-API-DMAC7.html) |
| NO (1) | NO20075825L (cg-RX-API-DMAC7.html) |
| NZ (1) | NZ561709A (cg-RX-API-DMAC7.html) |
| RU (1) | RU2412201C2 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2006113402A1 (cg-RX-API-DMAC7.html) |
| ZA (1) | ZA200708738B (cg-RX-API-DMAC7.html) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7455834B2 (en) * | 2002-06-29 | 2008-11-25 | Genentech, Inc. | Methods and compositions for modulating and detecting WISP activity |
| BR112014019741A2 (pt) | 2012-02-11 | 2020-12-22 | Genentech, Inc | Usos de um antagonista da via wnt, uso de uma terapia anticâncer, método de identificação de um indivíduo com câncer, métodos para prever, método de inibição da proliferação de uma célula de câncer, uso de um antagonista da translocação de r-spondina e antagonista da translocação de r-spondina isolado |
| KR20150134346A (ko) * | 2013-03-27 | 2015-12-01 | 지이 헬스케어 에이에스 | 진단 조성물을 제조하기 위한 방법 및 시약 |
| CN106456732A (zh) * | 2014-04-15 | 2017-02-22 | 索伦托治疗有限公司 | 结合wisp1的抗体疗法 |
| KR102011366B1 (ko) * | 2016-11-17 | 2019-10-14 | 연세대학교 산학협력단 | 암 전이 억제제의 스크리닝 방법 |
| EP4365299A3 (en) * | 2018-05-17 | 2024-08-07 | Olives Biotherapeutics Inc. | Pharmaceutical composition comprising ccn5 as active ingredient for preventing or treating retinal disease |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| US5206161A (en) | 1991-02-01 | 1993-04-27 | Genentech, Inc. | Human plasma carboxypeptidase B |
| WO1993008829A1 (en) | 1991-11-04 | 1993-05-13 | The Regents Of The University Of California | Compositions that mediate killing of hiv-infected cells |
| ATE406441T1 (de) | 1997-10-29 | 2008-09-15 | Genentech Inc | Verwendung des wnt-1 induzierten sekretierten polypeptids wisp-1 |
| PT1623990E (pt) | 1999-03-08 | 2008-03-18 | Genentech Inc | Composições e métodos para o tratamento de tumores |
| JP4636497B2 (ja) | 2002-06-29 | 2011-02-23 | ジェネンテック, インコーポレイテッド | Wisp活性を調節し検出するための方法及び組成物 |
| US7455834B2 (en) | 2002-06-29 | 2008-11-25 | Genentech, Inc. | Methods and compositions for modulating and detecting WISP activity |
| JP2007505131A (ja) | 2003-09-11 | 2007-03-08 | ジェネンテック・インコーポレーテッド | Wispアンタゴニストの使用方法 |
-
2005
- 2005-04-14 US US11/105,876 patent/US7455834B2/en not_active Expired - Lifetime
-
2006
- 2006-04-13 AU AU2006236649A patent/AU2006236649B2/en not_active Ceased
- 2006-04-13 MX MX2007012798A patent/MX2007012798A/es active IP Right Grant
- 2006-04-13 BR BRPI0612184A patent/BRPI0612184A8/pt active Search and Examination
- 2006-04-13 CA CA2604933A patent/CA2604933C/en not_active Expired - Fee Related
- 2006-04-13 NZ NZ561709A patent/NZ561709A/en not_active IP Right Cessation
- 2006-04-13 WO PCT/US2006/014008 patent/WO2006113402A1/en not_active Ceased
- 2006-04-13 JP JP2008506722A patent/JP4979684B2/ja not_active Expired - Lifetime
- 2006-04-13 KR KR1020077023542A patent/KR101320261B1/ko not_active Expired - Fee Related
- 2006-04-13 RU RU2007142005/10A patent/RU2412201C2/ru not_active IP Right Cessation
- 2006-04-13 ZA ZA200708738A patent/ZA200708738B/xx unknown
- 2006-04-13 EP EP06750127A patent/EP1869086B1/en not_active Expired - Lifetime
- 2006-04-13 CN CN2006800215473A patent/CN101198623B/zh not_active Expired - Lifetime
- 2006-04-13 ES ES06750127T patent/ES2388993T3/es not_active Expired - Lifetime
-
2007
- 2007-09-20 IL IL186095A patent/IL186095A/en not_active IP Right Cessation
- 2007-11-13 NO NO20075825A patent/NO20075825L/no not_active Application Discontinuation
-
2008
- 2008-10-20 US US12/254,649 patent/US7732567B2/en not_active Expired - Lifetime
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20150432T1 (hr) | Indentifikacija antigena povezanih s tumorom za dijagnozu i terapiju | |
| RU2012137503A (ru) | Лекарственный препарат для лечения и/или профилактики рака | |
| HRP20240495T1 (hr) | Anti-garp antitijelo | |
| CY1117031T1 (el) | Μονοκλωνικα αντισωματα εναντι claudin-18 στην αγωγη εναντι καρκινου | |
| FI3478723T3 (fi) | Pd-l1-spesifisiä vasta-aineita ja niiden käyttömenetelmiä | |
| SI2342234T1 (en) | MONOCOLIC ANTI-GT468 CANCER CANCER PROTITEL | |
| RU2013155455A (ru) | Антитела для лечения раковых заболеваний, при которых эскспрессируется клаудин 6 | |
| RU2013104830A (ru) | Лечение рака при помощи направленных на мишень антител in vivo | |
| RU2007136026A (ru) | Варианты ил-21 | |
| RU2014141151A (ru) | Диагностика и лечение злокачественной опухоли с использованием антитела против ereg | |
| RU2017138468A (ru) | Антитела против человеческого her3, имеющие низкое содержание фукозы, и области их применения | |
| CA3016333A1 (en) | Nanoliposomal targeting of ephrin receptor a2 (epha2) and related diagnostics | |
| RU2016146389A (ru) | Улучшенные полиэтилениминовые полиэтиленгликолевые векторы | |
| Choi et al. | A phase I study of nimotuzumab in combination with radiotherapy in stages IIB–IV non-small cell lung cancer unsuitable for radical therapy: Korean results | |
| HK1255815A1 (zh) | 治疗腹膜癌的组合物和方法 | |
| JP2015506961A5 (cg-RX-API-DMAC7.html) | ||
| MX2019009121A (es) | Antcuerpos anti-kaag1 o fragmento de union al antigeno del mismo para el tratamiento de cancer de mama triple negativo. | |
| MX2022005704A (es) | Peptidos antigenicos para la prevencion y el tratamiento de malignidad de celulas b. | |
| HRP20231636T1 (hr) | Igg epitop i njegova primjena kao cilja | |
| GB2474807A (en) | Vhz for diagnosis and treatment of cancers | |
| ME02725B (me) | Inhibitori proteazoma za lećenje kancera | |
| BRPI0707247B8 (pt) | vacina para tumor compreendendo células tumorais alogênicas ou xenogênicas | |
| RU2007142005A (ru) | Способы и композиции для модуляции и обнаружения активности wisp | |
| Hana et al. | Molecular Targeting of the Claudins Pathway. | |
| ES2348161T3 (es) | Métodos para dañar células usando funciones efectoras de anticuerpos anti-gfra1. |